Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effect of Endogenous Glucagon-like Peptide-1 on Glucagon Secretion in Type 1 Diabetes

NCT07373236 is registered in ClinicalTrials.gov with Asger Lund, MD as lead sponsor.

NCT NCT07373236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07373236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effect of Endogenous Glucagon-like Peptide-1 on Glucagon Secretion in Type 1 Diabetes
Lead sponsor
Asger Lund, MD
Phase
Not applicable
Overall status
Completed
Start date
January 23, 2026
Completion date
April 9, 2026
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes